Your browser doesn't support javascript.
loading
Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.
Peura, D A; Metz, D C; Dabholkar, A H; Paris, M M; Yu, P; Atkinson, S N.
Affiliation
  • Peura DA; University of Virginia Health Sciences Center, Charlottesville, VA, USA. dap8v@virginia.edu
Aliment Pharmacol Ther ; 30(10): 1010-21, 2009 Nov 15.
Article in En | MEDLINE | ID: mdl-19735233
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Delayed-Action Preparations / 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Delayed-Action Preparations / 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: United States Country of publication: United kingdom